![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Committee for Medicinal Products for Human Use, a committee of the European Medicines Agency (EMA) responsible for evaluating the quality, safety, and efficacy of human medicines for marketing authorization in the European Union.
Salesforce
CRM
Broadcom
AVGO
Qualcomm
QCOM
4
Oracle
ORCL
5
Netflix
NFLX
US Stock MarketDetailed Quotes
AKBA Akebia Therapeutics
- 2.221
- +0.061+2.82%
Trading Apr 24 10:23 ET
580.17MMarket Cap-6.73P/E (TTM)
2.230High2.160Low343.68KVolume2.160Open2.160Pre Close757.10KTurnover0.14%Turnover RatioLossP/E (Static)261.23MShares2.89052wk High-11.81P/B567.41MFloat Cap0.80052wk Low--Dividend TTM255.49MShs Float31.000Historical High--Div YieldTTM3.24%Amplitude0.241Historical Low2.202Avg Price1Lot Size
Akebia Therapeutics Stock Forum
Sign in to post a comment
$Akebia Therapeutics (AKBA.US)$ .. hold or sell?
1
$Akebia Therapeutics (AKBA.US)$
Major Win for Akebia: EMA Committee Recommends Novel Dual-Action Kidney Disease Treatment
Major Win for Akebia: EMA Committee Recommends Novel Dual-Action Kidney Disease Treatment
1
$Akebia Therapeutics (AKBA.US)$ Reuters· 5 mins ago
Akebia Therapeutics: Ec Will Review Chmp Recommendation, Final Decision Expected in About Two Months
Akebia Therapeutics: Ec Will Review Chmp Recommendation, Final Decision Expected in About Two Months
5
$Akebia Therapeutics (AKBA.US)$ This stock not stable!!!
$Akebia Therapeutics (AKBA.US)$ .. Why drop again??
I didn't expect this drop from day trading 11.37% gain. to 21% drop during post market, volatile... Dont be greedy and we will be ok :)
$Akebia Therapeutics (AKBA.US)$
$Akebia Therapeutics (AKBA.US)$
2
$Akebia Therapeutics (AKBA.US)$ latest news
“We are offering shares of our common stock.
Our common stock is listed on The Nasdaq Capital Market under the symbol “AKBA”. On March 18, 2025, the last reported sale price of our common stock on The Nasdaq Capital Market was $2.55 per share.”
“We are offering shares of our common stock.
Our common stock is listed on The Nasdaq Capital Market under the symbol “AKBA”. On March 18, 2025, the last reported sale price of our common stock on The Nasdaq Capital Market was $2.55 per share.”
1
$Akebia Therapeutics (AKBA.US)$ .. public offerring !!so drop dip.
1
$Akebia Therapeutics (AKBA.US)$ New high 52w
1
No comment yet
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
74398752 : hold don't chase the market just wait for the dust to settle download stocktwits app and follow AKBA board. Good luck